Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
3
×
national blog main
boston blog main
boston top stories
national top stories
san francisco blog main
black diamond therapeutics
bladder cancer
blueprint medicines
boston
brexanalone
cancer
cancer drugs
clinical data
clinical study
clinical trials
data
deciphera pharmaceuticals
depression
disease
eli lilly
endometral cancer
enzyme
europe blog main
european society for medical oncology
fda
gag
gene editing
genome editing
glioblastoma
hunter syndrome
ids
jeff jonas
loxo oncology
major depressive disorder
mental illness
mirati therapeutics
mps ii
mucopolysaccharidosis ii
What
phase
3
×
therapeutics
drug
trial
approval
benefit
biotech
black
brexanalone
cancer
clinic
companies
depression
diamond
editing
eluded
fda
gene
going
hits
hopes
hour
humans
infusion
ipo
isn't
landmark
lead
leading
lines
little
mark
medical
medicine
medicines
molecular
morning
nasdaq
nears
new
Language
unset
Current search:
phase
×
biotech
×
" life sciences "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
